Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › LA › Bastrop › NPI 1003898313
Hospital

Morehouse General Hospital

Morehouse General Hospital was paid $10.00M by Medicaid between Jan 2018 and Dec 2024, across 166 billing codes. Its largest line is 99283, emergency room visit (moderate) — 24% of everything it billed.

33Billing provider infoMOREHOUSE GENERAL HOSPITAL
BASTROP, LA 71220
33aNPI1003898313assigned 11/14/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$10.00M
24GClaims210,338
24DCodes billed166
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Louisiana

Rank by total paid#37 of 96
Median peer was paid$5.17M
This provider vs. median1.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201826,542$902K
201928,167$984K
202020,596$602K
202126,571$1.16M
202236,387$1.75M
202344,423$2.81M
2024incomplete27,652$1.79M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 24% 19,235 17,632 $2.41M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 23% 13,523 12,174 $2.29M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 6.9% 3,030 2,690 $691K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 5.3% 2,170 1,909 $528K
80050 General health panel 3.9% 9,764 8,695 $393K
74176 Computed tomography, abdomen and pelvis; without contrast material 3.7% 520 459 $374K
G0378 Hospital observation service, per hour 3.5% 1,178 648 $350K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 2.3% 10,870 9,114 $229K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 2.1% 1,104 1,035 $210K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 2.0% 4,130 3,668 $195K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) 1.7% 514 451 $172K
76830 Ultrasound, transvaginal 1.6% 809 766 $157K
154 more codes
71045 Radiologic examination, chest; single view 1.4% 3,312 $135K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 1.2% 455 $119K
G0379 Direct admission of patient for hospital observation care 1.1% 305 $115K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.1% 1,356 $111K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 4,950 $95K
70450 Computed tomography, head or brain; without contrast material <1% 762 $93K
36415 Collection of venous blood by venipuncture <1% 30,886 $72K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,638 $68K
80081 <1% 835 $59K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 1,900 $58K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 567 $50K
99213 Doctor's office visit, returning patient (routine) <1% 1,422 $50K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 986 $47K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 9,478 $43K
97597 <1% 1,372 $40K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 510 $37K
80053 Comprehensive metabolic panel <1% 6,247 $36K
99214 Doctor's office visit, returning patient (more involved) <1% 603 $32K
80061 Lipid panel <1% 2,728 $29K
81001 <1% 13,252 $29K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,368 $28K
87400 <1% 1,222 $28K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 868 $27K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 868 $27K
71046 Radiologic examination, chest; 2 views <1% 355 $25K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,398 $25K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 268 $24K
96375 Therapeutic injection; each additional sequential IV push <1% 658 $20K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 242 $20K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,103 $20K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 795 $19K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 60 $18K
94761 <1% 1,059 $16K
41899 Unlisted procedure, dentoalveolar structures <1% 28 $15K
84484 <1% 2,320 $14K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 338 $14K
0240U <1% 138 $14K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 459 $13K
82553 <1% 2,284 $12K
96361 Intravenous infusion, hydration; each additional hour <1% 484 $12K
72114 <1% 105 $11K
83021 <1% 625 $10K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 54 $10K
81025 <1% 1,478 $10K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 1,337 $9K
82550 <1% 2,501 $9K
83690 <1% 1,881 $8K
84481 <1% 712 $8K
84443 Thyroid stimulating hormone (TSH) <1% 592 $8K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 282 $8K
83880 <1% 460 $8K
87430 <1% 590 $8K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 159 $8K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 217 $7K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 221 $7K
86803 <1% 561 $7K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,640 $7K
83036 Hemoglobin; glycosylated (A1C) <1% 896 $7K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 257 $6K
84439 <1% 713 $5K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 836 $5K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 323 $5K
99203 Doctor's office visit, new patient (routine) <1% 135 $5K
94760 <1% 1,174 $5K
43235 <1% 14 $4K
0002A <1% 138 $4K
86762 <1% 280 $4K
82950 <1% 743 $3K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 890 $3K
87522 Neg quan hep c or qual rna <1% 78 $3K
87660 <1% 177 $3K
77067 Screening mammography, bilateral, including computer-aided detection <1% 28 $3K
73562 <1% 29 $3K
87340 <1% 337 $3K
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 313 $3K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 45 $3K
87480 <1% 178 $3K
87510 <1% 178 $3K
86592 <1% 733 $3K
J0595 Injection, butorphanol tartrate, 1 mg <1% 530 $3K
85660 <1% 512 $3K
83735 <1% 536 $2K
84702 <1% 170 $2K
85730 <1% 771 $2K
73130 <1% 13 $2K
0001A <1% 88 $2K
73564 <1% 13 $2K
J2704 Injection, propofol, 10 mg <1% 4,921 $2K
86850 <1% 718 $2K
85610 <1% 862 $2K
82670 <1% 57 $2K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 16 $2K
85014 <1% 782 $2K
85018 <1% 779 $2K
83655 <1% 121 $2K
36600 <1% 141 $1K
87186 <1% 169 $1K
82043 <1% 304 $1K
86704 <1% 100 $1K
86900 <1% 739 $1K
86706 <1% 100 $1K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 193 $1K
43450 <1% 746 $1K
86901 <1% 712 $1K
84402 <1% 45 $1K
84146 <1% 55 $1K
84403 <1% 44 $1K
82607 <1% 68 $949.50
74018 <1% 16 $940.60
88312 <1% 680 $937.94
82746 <1% 56 $749.16
87040 <1% 103 $746.74
86708 <1% 56 $726.94
82728 <1% 46 $494.59
J1170 Injection, hydromorphone, up to 4 mg <1% 71 $471.22
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 13 $468.97
77063 Screening digital breast tomosynthesis, bilateral <1% 14 $423.22
87521 Neg quan hep c or qual rna <1% 13 $421.08
87807 <1% 30 $408.80
87070 <1% 42 $405.92
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 44 $401.62
86705 <1% 29 $373.17
82803 <1% 117 $345.98
82677 <1% 15 $338.52
82105 <1% 29 $335.40
82150 <1% 71 $331.18
85027 <1% 91 $289.61
80320 <1% 26 $288.00
80179 <1% 24 $279.60
80143 <1% 24 $279.60
83001 <1% 15 $278.70
80048 Basic metabolic panel (calcium, ionized) <1% 60 $251.01
86140 <1% 70 $248.64
83550 <1% 29 $238.46
85379 <1% 41 $234.14
84134 <1% 40 $220.11
86336 <1% 15 $218.26
83540 <1% 29 $166.90
86709 <1% 16 $157.64
J2550 Injection, promethazine hcl, up to 50 mg <1% 60 $151.36
83605 <1% 31 $145.09
87350 <1% 13 $138.36
82570 <1% 34 $126.58
85651 <1% 41 $123.83
84156 <1% 34 $89.70
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 1,520 $87.31
J2060 Injection, lorazepam, 2 mg <1% 35 $69.28
85007 <1% 14 $34.10
J3010 Injection, fentanyl citrate, 0.1 mg <1% 27 $3.16
91300 0% 192 $0.00
90853 Group psychotherapy (other than of a multiple-family group) 0% 886 $0.00
T1015 A visit at a community health center or clinic (one all-in rate) 0% 44 $0.00
G0463 Hospital outpatient clinic visit for assessment and management of a patient 0% 516 $0.00
A4270 Disposable endoscope sheath, each 0% 25 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPATTERSON, ELMORE (CHIEF EXECUTIVE OFFICER)
Same official

Other billing entities under PATTERSON, ELMORE

Full network →
ProviderLocationPaid
Morehouse Parish Hospital Service District 1Bastrop, LA$3.51M
Morehouse General HospitalBastrop, LA$3.14M
Morehouse General HospitalBastrop, LA$1.60M
Morehouse General HospitalBastrop, LA$464K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.